Electroencephalography - Abnormal Activity and Diagnostic Criteria

Abnormal EEG Activity Introduction The electroencephalogram (EEG) is invaluable for detecting brain abnormalities. Not all abnormal EEG patterns carry the same significance: some patterns are highly suggestive of seizure disorders, while others simply reflect structural damage or metabolic problems. Understanding how to classify abnormal activity is essential for both clinical diagnosis and exam success. Epileptiform vs. Non-Epileptiform Patterns One of the most important distinctions you'll need to make is between epileptiform and non-epileptiform abnormalities. Epileptiform Discharges Epileptiform discharges are abnormal patterns that strongly suggest a propensity for seizures, even if the patient is not currently having one. These appear as fast, highly synchronous spikes—often with sharp waves—that stand out distinctly from the background brain activity. The key characteristic is their distinctive, stereotyped appearance: sharp transients that reflect pathological neuronal firing. The critical point is that epileptiform discharges can appear interictally—that is, between seizures. A patient wearing an EEG cap might show these patterns during normal waking or sleep, when no seizure is occurring. This is why epileptiform activity is so useful diagnostically: it reveals the brain's underlying irritability and increased seizure risk, even during symptom-free periods. Non-Epileptiform Abnormalities Non-epileptiform abnormalities reflect structural or metabolic dysfunction but do not specifically indicate seizure tendency. These include: Slowing: Loss of the normal fast rhythms you would expect for the patient's age and state (e.g., a loss of the normal alpha rhythm in an awake adult) Focal amplitude reduction: An area of the brain showing abnormally low electrical activity, suggesting structural damage Diffuse slowing: Widespread slow activity across both hemispheres Non-epileptiform patterns tell you something is wrong with the brain's health or structure, but they are less specific for epilepsy. For example, metabolic encephalopathy (brain dysfunction from systemic illness), diffuse head injury, or a deep midline lesion might all produce diffuse slowing without any epileptiform activity. Focal vs. Generalized Abnormalities The second key distinction concerns where the abnormality appears on the EEG. Focal Abnormalities Focal epileptiform discharges arise from a discrete, localized cortical area. Imagine a small region of the brain that has been damaged or is particularly irritable—it produces abnormal spikes in a limited set of electrode channels. This pattern has important implications: it suggests focal epilepsy, meaning seizures originate from that specific location. This is clinically valuable because it may indicate a focal lesion (such as a tumor, scar, or malformation) that could potentially be surgically removed. Generalized Abnormalities Generalized epileptiform discharges involve the entire brain simultaneously and synchronously. The spikes appear across all or most electrode channels at the same time. This pattern suggests a generalized epilepsy syndrome, where the seizure-generating mechanism involves the whole brain rather than a single region. Conditions like absence seizures or primary generalized tonic-clonic epilepsy typically show generalized discharges. Diffuse non-epileptiform slowing—bilateral delta activity across both hemispheres—can arise from several causes: Metabolic encephalopathy (sepsis, drug toxicity, renal failure, etc.) Diffuse brain injury Lesions affecting deep midline structures The key insight is that focal abnormalities point toward a local problem, while generalized patterns suggest a more widespread or systemic issue. EEG Applications in Clinical Practice Sleep Staging One of the most clinically important and frequently tested applications of EEG is sleep staging. The EEG changes dramatically across sleep stages, and specific patterns define each stage. Stage I (N1) NREM Sleep: As a patient transitions from wakefulness to sleep, the first sign is dropout of the posterior rhythm—the alpha activity that was prominent when awake disappears. This slow, rolling transition marks the beginning of sleep. Stage II (N2) NREM Sleep: The hallmark of stage II is the appearance of sleep spindles—brief bursts of activity at $12\text{–}14\text{ Hz}$ that last 1–2 seconds. These spindles appear and disappear periodically throughout the stage. You might also see K-complexes (large, biphasic waves), but the spindles are the classic marker. Stages III–IV (N3) NREM Sleep: The deepest stages of non-REM sleep are dominated by delta activity—slow waves at 0.5–2 Hz with high amplitude. The more delta activity, the deeper the sleep. Stage III shows 20–50% delta, while stage IV shows greater than 50% delta activity. Understanding these patterns is essential because sleep stage classification is used clinically to evaluate sleep disorders and is commonly tested on exams. Anesthesia Monitoring During general anesthesia, the EEG undergoes characteristic changes that correlate with the depth of sedation and the type of anesthetic drug being used. Clinicians monitor these patterns to ensure adequate anesthesia without excessive drug exposure. Specific EEG signatures emerge under anesthesia, such as widespread anterior rapid patterns, which correlate predictably with how deeply asleep (sedated) the patient is. This allows anesthesiologists to titrate drug doses more precisely and avoid both awareness during surgery and unnecessarily deep anesthesia, which can be harmful. <extrainfo> Advanced Biomarkers: Quantitative EEG Beyond visual interpretation of raw EEG traces, quantitative electroencephalography (qEEG) transforms regional brain activity into power-spectral measures. Rather than a clinician looking at squiggly lines, the computer calculates how much electrical activity is occurring at different frequencies in different brain regions. These quantitative measures can serve as biomarkers for various neurological and psychiatric conditions. For example, patients with Alzheimer's disease show characteristic changes in their power spectra, such as increased slow-frequency activity and decreased fast-frequency activity. Similarly, researchers have explored qEEG biomarkers for traumatic brain injury and PTSD, using objective frequency-domain measurements to complement clinical assessment. While qEEG is fascinating and increasingly important in research settings, it is less commonly used in routine clinical practice and may be less frequently tested than visual EEG interpretation skills. </extrainfo>